ASCO17 Archives - Pharmaphorum

High cost of cancer drugs takes centre stage at ASCO

https://pharmaphorum.com/news/high-cost-cancer-drugs-takes-centre-stage-asco/

Puma gains as Roche breast cancer combo disappoints

https://pharmaphorum.com/news/puma-gains-roche-breast-cancer-combo-disappoints/

ASCO round up: Zytiga shines in frontline prostate role, Loxo and Incyte pass early tests

https://pharmaphorum.com/news/asco-data-points-zytiga/

Lynparza first PARP drug to show promise in breast cancer

https://pharmaphorum.com/news/lynparza-first-parp-drug-show-promise-breast-cancer/

Spectacular early results for Novartis’ CAR-T combined with Imbruvica

https://pharmaphorum.com/news/spectacular-early-results-novartis-car-t-combined-imbruvica/

AZ highlights data from next-gen oncology drugs at ASCO

https://pharmaphorum.com/news/az-highlights-data-next-gen-oncology-drugs-asco/

ASCO 2017: Breast cancer next target for Keytruda

https://pharmaphorum.com/views-and-analysis/asco-2017-breast-cancer-keytruda/

Search